| Financial Year |
March 31 2023 |
| Monetary Funds |
912,185,500.24 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
418,522,913.40 |
| Accounts Receivable |
1,765,259,942.00 |
| Advances to Suppliers |
55,846,755.07 |
| Other Receivables |
40,587,973.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
684,317,468.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
28,500,000.00 |
| Other Current Assets |
98,744,202.93 |
| Total Current Assets |
4,140,689,426.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
48,198,460.48 |
| Investment Properties |
14,031,345.91 |
| Fixed Assetes |
2,498,460,143.04 |
| Under-construction Projects |
131,918,503.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
281,353,203.01 |
| R&D expenses |
16,182,704.28 |
| Goodwill |
759,972,215.28 |
| Long-Term Deferred and Prepaid Expenses |
73,219,964.26 |
| Deferred Income Tax Assets |
76,968,069.36 |
| Other Non-Current Assets |
44,377,747.38 |
| Sub-Total of Non-Current Assets |
4,179,578,276.72 |
| Total Assets |
8,320,267,703.47 |
| Short-Term Loans |
587,394,104.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
257,035,108.65 |
| Accounts Payable |
591,673,475.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
179,796,521.75 |
| Taxes Payable |
69,347,722.95 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
120,092,361.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
572,420,005.81 |
| Other Current Liabilities |
233,287,157.27 |
| Sub-Total of Current Liabilities |
2,678,607,617.46 |
| Long-term Loans |
513,497,423.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
65,582,963.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
692,046,525.22 |
| Total Liabilities |
3,370,654,142.68 |
| Paid-In Capital(Or Share Stock) |
1,259,898,562.00 |
| Capital Surplus |
284,906,019.73 |
| Surplus Reserve |
215,237,834.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,846,687,957.04 |
| Minority Stockholder's Interest |
451,219,013.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,498,394,547.23 |
| Owner's Equity（Stockholder's Equity） |
4,949,613,560.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,320,267,703.47 |
